U.S. Industrial REITs Stock News

A week ago, Ironwood Pharmaceuticals, Inc. ( NASDAQ:IRWD ) came out with a strong set of quarterly numbers that could...

Shareholders in Ionis Pharmaceuticals, Inc. ( NASDAQ:IONS ) may be thrilled to learn that the analysts have just...

Shareholders might have noticed that Nektar Therapeutics ( NASDAQ:NKTR ) filed its quarterly result this time last...

Unsurprisingly, Illumina, Inc.'s ( NASDAQ:ILMN ) stock price was strong on the back of its healthy earnings report. We...

A week ago, Callaway Golf Company ( NYSE:CALY ) came out with a strong set of quarterly numbers that could potentially...

Cencora, Inc. ( NYSE:COR ) is about to trade ex-dividend in the next three days. The ex-dividend date occurs one day...

Over the past year, insiders sold US$67k worth of Sypris Solutions, Inc. ( NASDAQ:SYPR ) stock at an average price of...

Some Bank of America Corporation ( NYSE:BAC ) shareholders may be a little concerned to see that insider Geoffrey...

In early May 2026, PTC Therapeutics reported first-quarter revenue of US$272.55 million versus US$1.18 billion a year earlier, swinging from net income of US$866.56 million to a net loss of US$2.81 million while still beating analyst expectations on both revenue and earnings per share. The company also released positive 24-month interim data for Huntington’s disease therapy votoplam and raised its 2026 product revenue guidance, underscoring how a strong Sephience launch and advancing...

Southside Bancshares (SBSI) drew fresh attention after reporting first quarter 2026 results and affirming a quarterly dividend of $0.36 per share, pairing earnings information with a continued cash return to shareholders. See our latest analysis for Southside Bancshares. The recent first quarter update and confirmed dividend come after a steadily improving share price. The 1 month share price return was 5.12% and the year to date share price return was 10.51%, alongside a 1 year total...

Why Excelerate Energy is on investors’ radar Excelerate Energy (EE) has drawn fresh attention after recent trading left the stock with a year to date total return of 19.58% and a 1 year total return of 17.62%, against a last close of US$33.89. See our latest analysis for Excelerate Energy. Recent trading has been choppy, with the share price up 2.5% on the day to US$33.89 but down over 13% on a 3 month share price return. This compares with a stronger 3 year total shareholder return of 62.2%,...

ManpowerGroup recently reported its Q1 2026 results, showing 10.3% revenue growth, significantly higher taxes that reduced net earnings to US$2.5 million, completion of the US$100 million sale of its Jefferson Wells U.S. finance and accounting business, and Board approval of a semi-annual US$0.72 per share dividend payable on June 15, 2026 to shareholders of record on June 1, 2026. Alongside these operational updates, shareholders approved an expanded and extended equity incentive plan and...

UFP Technologies (UFPT) just paired its Q1 2026 earnings with a clear push on acquisitions, as management highlighted a full deal pipeline, ongoing bids, and a disciplined filter on price, culture, and fit. See our latest analysis for UFP Technologies. The Q1 2026 earnings update and acquisition commentary have arrived alongside a sharp swing in sentiment, with a 19.7% 7 day share price return and a 14.6% 30 day share price return partly offsetting a 13.8% 90 day decline and leaving the 1...

Q1 earnings spark fresh interest in Lincoln Electric Holdings (LECO) Lincoln Electric Holdings (LECO) is back on investor radar after reporting first quarter sales of US$1,121.43 million and net income of US$136.38 million, both above the prior year period. See our latest analysis for Lincoln Electric Holdings. The earnings beat comes after a mixed share price run, with the stock up 11.22% year to date and delivering a 40.97% total shareholder return over one year. However, the 90 day share...

Fidelis Insurance Holdings Limited recently declared a quarterly dividend of US$0.15 per share, payable on June 26, 2026, following shareholder approval of bye-law amendments and ahead of its rebrand to Pelagos Insurance Capital Limited on May 11, 2026. Alongside this cash return, the company completed the repurchase of all remaining shares held by former principal shareholder CVC Falcon Holdings Limited, simplifying its ownership structure and removing a private equity governance...

In early May 2026, Crinetics Pharmaceuticals reported first-quarter revenue of about US$10.73 million, up sharply from roughly US$0.36 million a year earlier, alongside a wider net loss of about US$127.85 million and basic loss per share of US$1.23. Shortly before these results, the European Commission approved PALSONIFY (paltusotine) as the first once-daily oral therapy for adult acromegaly across the EU and EEA, reinforcing Crinetics’ shift into a commercial-stage rare disease business...

Ryerson Holding Corporation recently reported past first-quarter 2026 results, with sales rising to US$1,566.5 million and net income reaching US$4.5 million, alongside a return to positive earnings per share from continuing operations. On the same day, the company also filed a US$50.22 million shelf registration for 1,800,000 common shares tied to an ESOP-related offering, underscoring its use of equity for employee benefit plans. We will now examine how Ryerson’s return to profitability...

Taysha Gene Therapies (TSHA) has reaffirmed FDA alignment on the Biologics License Application pathway for TSHA-102, including pivotal trial design and the potential use of a six month interim analysis for approval. See our latest analysis for Taysha Gene Therapies. The reaffirmed FDA pathway comes after a run in the stock, with a 30 day share price return of 45.95% and a 1 year total shareholder return of 217.62%. This signals strong momentum despite recent earnings losses and ongoing cash...

Liberty Live Holdings, Inc. reported first-quarter 2026 results, with revenue rising to US$63.62 million from US$47.06 million a year earlier, while net loss widened to US$294.14 million from US$29.48 million. This combination of higher sales and a much larger loss highlights how Liberty Live Holdings is balancing growth with the cost of its operations. Next, we’ll examine how the sharp increase in net loss alongside revenue growth shapes Liberty Live Holdings’ broader investment...

Huntsman Corporation recently reported first-quarter 2026 results showing sales of US$1,420 million and a net loss of US$53 million, while shareholders voted against a proposal for an independent board chair and the company affirmed a quarterly dividend of US$0.0875 per share. These developments, alongside ongoing restructuring and European plant-closure programs discussed in earlier filings, highlight the cost and governance pressures shaping Huntsman’s current operating profile. We’ll now...

TowneBank (TOWN) stock drew attention after recent trading left it modestly higher over the past week, but lower over the past month and over the past three months, prompting closer inspection of its fundamentals. See our latest analysis for TowneBank. At a share price of $34.99, TowneBank has a 1-day share price return of 0.46% and a year to date share price return of 5.33%, while its 3 year total shareholder return of 80.75% points to stronger momentum over the longer term. If TowneBank’s...

Host Hotels & Resorts (HST) is in focus after reporting first quarter 2026 results that exceeded profitability expectations, lifted its full year comparable hotel RevPAR guidance, and paired asset sale gains with a special dividend announcement. See our latest analysis for Host Hotels & Resorts. The share price has reacted positively to the first quarter update, with a 1 day share price return of 2.77% and a 7 day share price return of 6.76%. The 1 year total shareholder return of 49.75% and...

ArriVent BioPharma (AVBP) drew fresh attention after announcing FDA clearance of its investigational new drug application for ARR-002, a first-in-class dual-target antibody-drug conjugate for ovarian and endometrial cancers. See our latest analysis for ArriVent BioPharma. Despite a recent dip, with a 1 day share price return down 2.60% and 7 day share price return down 7.20%, ArriVent’s 30 day and year to date share price returns of 14.53% and 38.70%, alongside a 1 year total shareholder...

USA TODAY (TDAY) stock is in focus after the company returned to profitability in the first quarter of 2026, posting positive net income and reaffirming full year earnings guidance despite lower revenue. See our latest analysis for USA TODAY. The earnings return to profit and reaffirmed 2026 guidance have arrived alongside strong momentum, with a 90 day share price return of 26.96% and a 1 year total shareholder return of 105.66%, suggesting sentiment has strengthened around the earnings...